| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership change | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-06-09 | Posner Brian S Director | Purchase | +2,000 | +8.89%24,500 | $16.94 | $33,880 | View SEC filing | |
| 2026-06-05 | Posner Brian S Director | Purchase | +2,500 | +12.50%22,500 | $17.48 | $43,700 | View SEC filing | |
| 2026-05-28 | Posner Brian S Director | Purchase | +2,000 | +11.11%20,000 | $18.21 | $36,420 | View SEC filing | |
| 2026-05-22 | Posner Brian S Director | Purchase | +2,500 | +16.13%18,000 | $17.12 | $42,800 | View SEC filing | |
| 2026-05-14 | Friedl-Naderer Johanna Chief Commercial Officer | Sale | -228 | -0.15%154,353 | $18.36 | $4,186 | View SEC filing | |
| 2026-05-14 | Kerr Douglas Chief Medical Officer | Sale | -1,564 | -0.91%170,042 | $18.36 | $28,715 | View SEC filing | |
| 2026-05-14 | Lucera Erick Chief Financial Officer | Sale | -1,448 | -1.15%123,925 | $18.36 | $26,585 | View SEC filing | |
| 2026-05-14 | Cox John CEO & President | Sale | -3,311 | -0.88%370,834 | $18.36 | $60,790 | View SEC filing | |
| 2026-05-06 | Rhodes Jason P Director | Sale | -106,723 | -27.93%1,136,810 | $18.14 | $1,936,341 | View SEC filing | |
| 2026-04-30 | Rhodes Jason P Director | Sale | -227,337 | -29.22%1,158,923 | $18.38 | $4,178,516 | View SEC filing | |
| 2026-04-23 | Rhodes Jason P Director | Sale | -384,549 | -30.63%1,206,026 | $18.47 | $7,101,120 | View SEC filing | |
| 2026-04-23 | Kersten Dirk Director | Sale | -10,952 | -0.26%4,196,573 | $20.01 | $219,170 | View SEC filing | |
| 2026-04-22 | Rhodes Jason P Director | Sale | -834,302 | -34.35%1,285,704 | $19.75 | $16,477,388 | View SEC filing | |
| 2026-04-21 | Kersten Dirk Director | Sale | -337,248 | -7.42%4,207,525 | $20.21 | $6,815,190 | View SEC filing | |
| 2026-04-17 | Kersten Dirk Director | Sale | -99,613 | -2.14%4,544,773 | $20.35 | $2,027,158 | View SEC filing | |
| 2026-04-03 | Lucera Erick Chief Financial Officer | Sale | -5,727 | -4.37%125,373 | $18.64 | $106,751 | View SEC filing | |
| 2026-04-01 | Posner Brian S Director | Purchase | +2,000 | +14.81%15,500 | $17.08 | $34,160 | View SEC filing | |
| 2026-03-13 | Posner Brian S Director | Purchase | +2,000 | +17.39%13,500 | $19.35 | $38,700 | View SEC filing | |
| 2026-03-13 | Kersten Dirk Director | Sale | -129,672 | -2.72%4,644,386 | $19.52 | $2,530,562 | View SEC filing | |
| 2026-03-11 | Kersten Dirk Director | Sale | -688,788 | -12.61%4,774,058 | $19.09 | $13,149,314 | View SEC filing | |
| 2026-03-10 | Posner Brian S Director | Purchase | +3,000 | +35.29%11,500 | $15.06 | $45,180 | View SEC filing | |
| 2026-03-06 | Friedl-Naderer Johanna Chief Commercial Officer | Sale | -148 | -0.10%154,581 | $14.90 | $2,205 | View SEC filing | |
| 2026-03-06 | Kerr Douglas Chief Medical Officer | Sale | -904 | -0.52%171,606 | $14.90 | $13,470 | View SEC filing | |
| 2026-03-06 | Cox John CEO & President | Sale | -2,732 | -0.72%374,145 | $14.90 | $40,707 | View SEC filing | |
| 2025-12-05 | Cox John CEO & President | Sale | -2,662 | -1.33%196,877 | $20.72 | $55,157 | View SEC filing |
1-25 of 196
